Signals, Powered By EquityPandit
A rollout of Gemcitabine InfuSMART which is used in the treatment of cancer, in Europe, has been announced by Sun Pharmaceutical Industries.
The company has said in a BSE filing that “As part of its business strategy to build a meaningful and differentiating presence in global oncology therapy market, Sun Pharma has announced rollout of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag.”
